CONMED - CNMD Stock Forecast, Price & News

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CONMED in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" CNMD shares.
View CNMD analyst ratings or view top-rated stocks.

1 Wall Street analysts have issued 1 year price targets for CONMED's stock. Their CNMD share price forecasts range from $106.00 to $106.00. On average, they predict the company's share price to reach $106.00 in the next twelve months. This suggests a possible upside of 21.8% from the stock's current price.
View analysts price targets for CNMD or view top-rated stocks among Wall Street analysts.

CONMED's stock was trading at $79.06 on January 1st, 2022. Since then, CNMD stock has increased by 10.0% and is now trading at $87.00.
View the best growth stocks for 2022 here.

CONMED saw a increase in short interest in the month of October. As of October 31st, there was short interest totaling 3,300,000 shares, an increase of 5.1% from the October 15th total of 3,140,000 shares. Based on an average daily volume of 364,400 shares, the short-interest ratio is currently 9.1 days.
View CONMED's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, January 25th 2023.
View our CNMD earnings forecast.

CONMED Co. (NYSE:CNMD) issued its quarterly earnings data on Wednesday, October, 26th. The company reported $0.77 EPS for the quarter, topping the consensus estimate of $0.75 by $0.02. The firm earned $275.09 million during the quarter, compared to the consensus estimate of $282.23 million. CONMED had a positive trailing twelve-month return on equity of 14.00% and a negative net margin of 7.74%.

CONMED announced a quarterly dividend on Monday, December 5th. Investors of record on Friday, December 16th will be paid a dividend of $0.20 per share on Thursday, January 5th. This represents a $0.80 annualized dividend and a yield of 0.92%. The ex-dividend date of this dividend is Thursday, December 15th.
Read our dividend analysis for CNMD.

CONMED (NYSE:CNMD) pays an annual dividend of $0.80 per share and currently has a dividend yield of 0.93%.
Read our dividend analysis for CNMD.

CONMED updated its FY 2023 earnings guidance on Tuesday, November, 15th. The company provided earnings per share (EPS) guidance of $3.20-$3.50 for the period, compared to the consensus estimate of $3.39. The company issued revenue guidance of $1.17 billion-$1.23 billion, compared to the consensus revenue estimate of $1.21 billion.

CONMED trades on the New York Stock Exchange (NYSE) under the ticker symbol "CNMD."

CONMED's stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (15.77%), Vanguard Group Inc. (10.95%), State Street Corp (3.53%), Macquarie Group Ltd. (2.41%), Dimensional Fund Advisors LP (2.10%) and AXA S.A. (1.96%).

Shares of CNMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CNMD stock can currently be purchased for approximately $87.00.

CONMED (NYSE:CNMD) has a market capitalization of $2.65 billion and generates $1.01 billion in revenue each year. The company earns $62.54 million in net income (profit) each year or ($2.95) on an earnings per share basis.

The company employs 3,800 workers across the globe.

CONMED's mailing address is 525 FRENCH ROAD, UTICA NY, 13502. The official website for the company is www.conmed.com. The company can be reached via phone at (727) 392-6464 or via fax at 315-797-0321.